Chief of Staff
Adam Camiel is Chief of Staff for Servier Pharmaceuticals. He oversees the framework of the organization, identifying and acting upon efficiencies and interdependencies to further the strategic vision for current and future company initiatives. Adam works dynamically as a thought partner to influence outcomes and maintain momentum, adding his unique perspective as a former deal lawyer.
Adam comes to Servier Pharmaceuticals from McDermott Will & Emery LLP, where he specialized in life science licensing and collaboration transactions, mergers & acquisitions and healthcare regulatory counsel. Adam’s unique background enabled him to advise a broad scope of pharmaceutical, biotech, and digital health clients. Prior to becoming a corporate lawyer, Adam spent several years at Novartis, Baxalta, and Shire leading large cross-functional projects and operations in finance, strategic planning, and marketing capacities.
Adam received his Bachelor of Science from Babson College and his J.D. and M.B.A. from Suffolk University.
To learn more about Adam, connect with him on LinkedIn.
More from Servier
Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.Learn More
Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.Learn More
Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history.Learn More